Tag: Opioids
In Pregnancy, Buprenorphine Use Up, Methadone Use Down
And the 4Ps Plus and SURP-P scale are sensitive for identifying illicit drug use in pregnancy
CDC Clarifies Guideline on Opioid Prescribing for Chronic Pain
Clarification pertains to opioid prescribing for cancer patients, cancer survivors, sickle cell disease
FDA: Patients Should Not Abruptly Stop Taking a Prescribed Opioid
Agency warns that rapid discontinuation can result in uncontrolled pain or withdrawal symptoms
Many NPs Unable to Prescribe Meds to Treat Opioid Addiction
Greater practice restrictions lead to lower percentage of NPs with waivers to prescribe buprenorphine
Receiving Activated Charcoal Bag Tied to Proper Opioid Disposal
Less medication flushing, inappropriate garbage disposal seen for those receiving activated charcoal bag
Hearing Loss Before Age 50 Tied to Higher Substance Use
Associations particularly pronounced for Rx opioid use disorders in those aged 18 to 34 with hearing loss
Analgesics in Pregnancy Do Not Seem to Cause Offspring Asthma
Sibling comparison analysis suggested association confounded by specific maternal factors
Opioid Prescriptions Dropped for New Users From 2012 to 2017
Decline seen in number of providers initiating opioid therapy in any patients who have not used opioids
Four-to-Seven-Day Opioid Rx Likely Sufficient for Acute Pain Treatment
No more than one in five patients who filled an opioid analgesic prescription obtained a refill
Dual Receipt of Opioids Tied to Increased Risk for OD Death
Those enrolled in both VA and Medicare Part D have higher odds of death from Rx opioid overdose